$2.86
-0.12-4.03%
At close: -
$2.77
-0.09-3.15%
After Hours: 7:21 PM EDT
Comments
Loading...
Latest CureVac Stock News | NASDAQ:CVAC | Benzinga
Get the latest news on CureVac stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on CureVac performance
Categories: All
Thursday, April 10, 2025
Wednesday, April 09, 2025
Monday, April 07, 2025
Tuesday, April 01, 2025
Friday, March 28, 2025
- Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday
- European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps
- CureVac shares are trading higher after the c...
- Market-Moving News for March 28th
Thursday, March 27, 2025
Wednesday, February 26, 2025
Friday, February 14, 2025
Thursday, February 13, 2025
Wednesday, February 12, 2025
Thursday, January 30, 2025
Wednesday, January 29, 2025
Friday, January 24, 2025
Tuesday, January 21, 2025
Thursday, January 16, 2025
Friday, January 10, 2025
Wednesday, January 08, 2025
Tuesday, January 07, 2025
Monday, January 06, 2025
Tuesday, November 12, 2024
Monday, November 11, 2024
Monday, November 04, 2024
Tuesday, October 08, 2024
Monday, September 16, 2024
Friday, September 13, 2024
Thursday, September 12, 2024
Friday, August 16, 2024
Thursday, August 15, 2024
Thursday, July 11, 2024
Wednesday, July 03, 2024
- JMP Securities Reiterates Market Outperform o...
- GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
- CureVac shares are trading higher after the c...
- CureVac Secures €400M Upfront and Up to €1.05...
- CureVac Restructures to Focus on High-Value m...
- GSK and CureVac Restructure Partnership, Focu...